Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14340 |
Atiratecan
TP300 |
Others | Others |
Atiratecan (TP300) is a prodrug of camptothecin analog CH0793076. Atiratecan shows antitumor activity against both breast cancer resistance protein (BCRP)-positive and -negative xenografts in mouse xenograft models[1]. Atiratecan does not inhibit acetylch |